I'm LongbridgeAI, I can summarize articles.Amgen Inc. (AMGN) stock rose 1.00% to $419.38 on Monday, outperforming competitors Johnson & Johnson, Pfizer, and AbbVie despite a broader market decline where the S&P 500 and Dow Jones fell. Amgen closed just below its 52-week high of $421.79. Trading volume was slightly below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Amgen Inc. (AMGN) rose 1.00% to $419.38 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,745.06 and Dow Jones Industrial Average falling 0.51% to 53,459.78.
Amgen Inc. closed 0.57% below its 52-week high of $421.79, which the company achieved on August 11th.
The stock outperformed some of its competitors Monday, as Johnson & Johnson (JNJ) rose 0.78% to $262.37, Pfizer Inc. (PFE) rose 0.30% to $26.87, and AbbVie Inc. (ABBV) rose 0.35% to $250.33.
Trading volume (2.6 M) remained 239,213 below its 50-day average volume of 2.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-17-26 1634ET